Profile's ShareDataOnline
Google
 ASPEN
  • Home Page
    		•
  • Glossies
    		•
  • Forecasts
    		•
  • Email Alerts
    		•
    News
  • Latest News
    		•
  • Archive
    		•
  • SENS
    		•
  • Dir Dealings
    		•
    Fact Sheets
  • Summary
    		•
  • Detailed
    		•
  • Valuation
    		•
    Performance
  • Performance
    		•
  • Market Stats
    		•
  • Intraday
    		•
    Results
  • Comment
    		•
  • In Brief
    		•
  • Analysis
    		•
  • In Full
    		•
     
     Latest News: Aspen Pharmacare Holdings Ltd. ASPEN [APN]
     Tue, 28 Oct 2025 Media Comment [TN] 
    Aspen targets Africa for weight-loss drug
    According to the Business Day, multinational drugmaker, Aspen announced its strategy to expand the recently launched weight-loss drug, Mounjaro to the rest of Africa next year, strengthening its foothold in the fast-growing therapeutic market. Aspen. in partnership with Eli Lily launched the Mounjaro vials in South Africa in December 2024 for the treatment of type 2 diabetes. The launch of the drug contributed positively to earnings in the six months to June.

    Sales of the drug have surged and the group expects further growth, with R1 billion of sales expected within the next few years.
     
     
    Click here for full news archive for this company
    Closing price data source: JSE Ltd. All other statistics calculated by ProfileData.
       
    Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
    Other Profile Group sites: FundsData Online (unit trust data) | Profile Group corporate site
    [  Terms of Conditions |  Privacy Policy |  PAIA manual |  Site Map |  © Copyright Reserved 2025  ]
      


    Powered by ProfileData


    Follow us on:

    Show me the New ShareData Online message.